These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28139967)

  • 1. The globalisation strategies of five Asian tobacco companies: a comparative analysis and implications for global health governance.
    Lee K; Eckhardt J
    Glob Public Health; 2017 Mar; 12(3):367-379. PubMed ID: 28139967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Preparing ourselves to become an international organization': Thailand Tobacco Monopoly's regional and global strategies.
    MacKenzie R; Ross H; Lee K
    Glob Public Health; 2017 Mar; 12(3):351-366. PubMed ID: 28139965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The China National Tobacco Corporation: From domestic to global dragon?
    Fang J; Lee K; Sejpal N
    Glob Public Health; 2017 Mar; 12(3):315-334. PubMed ID: 27737622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KT&G: From Korean monopoly to 'a global name in the tobacco industry'.
    Lee K; Gong L; Eckhardt J; Holden C; Lee S
    Glob Public Health; 2017 Mar; 12(3):300-314. PubMed ID: 28139963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japan Tobacco International: To 'be the most successful and respected tobacco company in the world'.
    MacKenzie R; Eckhardt J; Widyati Prastyani A
    Glob Public Health; 2017 Mar; 12(3):281-299. PubMed ID: 28139966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Taiwan Tobacco and Liquor Corporation: To 'join the ranks of global companies'.
    Eckhardt J; Fang J; Lee K
    Glob Public Health; 2017 Mar; 12(3):335-350. PubMed ID: 28139964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The globalisation strategies of five Asian tobacco companies: An analytical framework.
    Lee K; Eckhardt J
    Glob Public Health; 2017 Mar; 12(3):269-280. PubMed ID: 27884083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creating demand for foreign brands in a 'home run' market: tobacco company tactics in South Korea following market liberalisation.
    Lee S; Lee K; Holden C
    Tob Control; 2014 May; 23(3):e8. PubMed ID: 23152099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are transnational tobacco companies' market access strategies linked to economic development models? A case study of South Korea.
    Lee S; Holden C; Lee K
    Glob Public Health; 2013; 8(4):435-48. PubMed ID: 23327486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the impacts of tobacco industry privatisation: Implications for policy.
    Gilmore AB; Fooks G; McKee M
    Glob Public Health; 2011; 6(6):621-42. PubMed ID: 21790502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From transit hub to major supplier of illicit cigarettes to Argentina and Brazil: the changing role of domestic production and transnational tobacco companies in Paraguay between 1960 and 2003.
    Iglesias RM; Gomis B; Carrillo Botero N; Shepherd P; Lee K
    Global Health; 2018 Nov; 14(1):111. PubMed ID: 30454015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials.
    Gilmore AB
    Tob Control; 2012 Mar; 21(2):119-26. PubMed ID: 22345234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving East: how the transnational tobacco industry gained entry to the emerging markets of the former Soviet Union-part I: establishing cigarette imports.
    Gilmore AB; McKee M
    Tob Control; 2004 Jun; 13(2):143-50. PubMed ID: 15175531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. British American Tobacco's failure in Turkey.
    Lawrence S
    Tob Control; 2009 Feb; 18(1):22-8. PubMed ID: 18845622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving East: how the transnational tobacco industry gained entry to the emerging markets of the former Soviet Union-part II: an overview of priorities and tactics used to establish a manufacturing presence.
    Gilmore AB; McKee M
    Tob Control; 2004 Jun; 13(2):151-60. PubMed ID: 15175532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can demand-side policies stop the tobacco industry's damage? Lessons from Turkey.
    Gultekin-Karakas D
    Glob Public Health; 2015; 10(7):777-93. PubMed ID: 25640333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'It will harm business and increase illicit trade': an evaluation of the relevance, quality and transparency of evidence submitted by transnational tobacco companies to the UK consultation on standardised packaging 2012.
    Evans-Reeves KA; Hatchard JL; Gilmore AB
    Tob Control; 2015 Jun; 24(e2):e168-77. PubMed ID: 25472733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "We think globally": the rise of Paraguay's Tabacalera del Este as a threat to global tobacco control.
    Gomis B; Lee K; Carrillo Botero N; Shepherd P; Iglesias RM
    Global Health; 2018 Nov; 14(1):110. PubMed ID: 30454045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing with kreteks: transnational tobacco companies, globalisation, and Indonesia.
    Lawrence S; Collin J
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii96-103. PubMed ID: 15564227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.